.png)
Long Covid, ME/CFS, MCAS & EDS
Under the care of Dr. Michael Scoma, patients receive advanced, precision-based treatment for Long COVID, ME/CFS, MCAS, and Ehlers-Danlos syndrome. Through targeted antiviral and monoclonal therapies, along with neuromodulatory and immunologic interventions, we address post-viral immune dysregulation, neuroinflammation, autonomic dysfunction, mast cell activation, and systemic inflammation—supporting long-term recovery and improved quality of life.
Among the elite providers nationwide offering prolonged antiviral and monoclonal antibody therapies for Long COVID and vaccine-related injuries, using advanced clinical protocols.
Expert management of immune, neurologic, autonomic, and endothelial complications post-COVID, with focused treatments for neuroinflammation and autonomic dysfunction.
Use of neuromodulatory and immunologic therapies to target root causes of chronic inflammation and immune dysregulation in Long COVID and ME/CFS.
Expert care for ME/CFS and chronic post-viral syndromes, including viral reactivations, with individualized treatment addressing sleep, autonomic dysfunction, immune-metabolic imbalance, and post-exertional malaise.
Advanced management of MCAS and Ehlers-Danlos syndrome with personalized, root-cause–driven treatment for overlapping post-viral and autonomic dysfunction.
Tailored protocols addressing fatigue, cognitive symptoms, cardiovascular effects, and systemic inflammation aimed at long-term recovery and improved quality of life.
